WallStreetZenWallStreetZen

NASDAQ: TRAW
Traws Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TRAW past revenue growth

How has TRAW's revenue growth performed historically?
Company
0%
Industry
144.63%
Market
17.55%
TRAW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TRAW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TRAW's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TRAW earnings and revenue history

Current Revenue
$226.0k
Current Earnings
-$18.9M
Current Profit Margin
-8,384.1%

TRAW Return on Equity

Current Company
-113.2%
Current Industry
-63.5%
Current Market
188%
TRAW's Return on Equity (-113.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TRAW announces earnings.

TRAW Return on Assets

Current Company
-65.8%
Current Industry
2.9%
TRAW is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TRAW Return on Capital Employed

Current Company
-140.74%
Current Industry
19.5%
TRAW has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRAW vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TRAW$226.00k-$18.93M-$18.95M-28.72%N/A
NNVC$0.00-$8.55M-$9.36MN/AN/A
XTLB$0.00-$1.35M-$1.35MN/AN/A
SNTI$2.56M-$65.63M-$71.06M+152.19%N/A
MIRA$0.00-$8.53M-$11.98MN/AN/A
View Top Biotech Stocks

TRAW earnings dates

Next earnings date
May 13, 2024

Traws Pharma Earnings & Revenue FAQ

What were TRAW's earnings last quarter?

On Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q4 2023 earnings per share (EPS) of -$0.20, up 23.08% year over year. Total Traws Pharma earnings for the quarter were -$4.18 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Traws Pharma stock.

What was TRAW's earnings growth in the past year?

As of Q2 2024, Traws Pharma's earnings has grown year over year. Traws Pharma's earnings in the past year totalled -$18.95 million.

What is TRAW's earnings date?

Traws Pharma's earnings date is Invalid Date. Add TRAW to your watchlist to be reminded of TRAW's next earnings announcement.

What was TRAW's revenue last quarter?

On Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q4 2023 revenue of $56.00 thousand up 0% year over year. In the same quarter last year, Traws Pharma's revenue was $56.00 thousand.

What was TRAW's revenue growth in the past year?

As of Q2 2024, Traws Pharma's revenue has grown 0% year over year. This is 144.63 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Traws Pharma's revenue in the past year totalled $226.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.